Cargando…
Prognostic Value Analysis of Mutational and Clinicopathological Factors in Non-Small Cell Lung Cancer
INTRODUCTION: Targeting activating oncogenic driver mutations in lung adenocarcinoma has led to prolonged survival in patients harboring these specific genetic alterations. The prognostic value of these mutations has not yet been elucidated. The prevalence of recently uncovered non-coding somatic mu...
Autores principales: | Li, Chenguang, Hao, Ligang, Li, Yue, Wang, Shengguang, Chen, Hui, Zhang, Lianmin, Ke, Bin, Yin, Yuesong, Suo, Haijin, Sun, Bingsheng, Zhang, Bin, Wang, Changli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157862/ https://www.ncbi.nlm.nih.gov/pubmed/25198510 http://dx.doi.org/10.1371/journal.pone.0107276 |
Ejemplares similares
-
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
por: Liu, Weiran, et al.
Publicado: (2016) -
Prognostic value of number of negative lymph node in patients with stage II and IIIa non-small cell lung cancer
por: Wang, Shengguang, et al.
Publicado: (2017) -
Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Hua, et al.
Publicado: (2016) -
Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer
por: Gao, Liuwei, et al.
Publicado: (2017) -
PinX1 Is a Potential Prognostic Factor for Non-Small-Cell Lung Cancer and Inhibits Cell Proliferation and Migration
por: Wang, Shengguang, et al.
Publicado: (2017)